August 01, 2014 - MM&M - Medical Marketing and Media

Print Issue: August 01, 2014

Can value vanquish payer pressure?

Pharma cites “payer pressure” as one of its biggest marketing challenges yet struggles to make the “value” case for products. How can it translate market-access awareness into reimbursement success?

MM&M Awards 2014: The Final Cut

MM&M Awards 2014: The Final Cut

More than 100 esteemed industry leaders and thinkers spent several hours discussing, reviewing and scoring around 700 entries to the MM&M Awards. Here are the results of their efforts—the 2014 finalists

Analysts haven't soured on Yervoy, despite miss in prostate cancer

Therapeutic Focus 2014: Oncology

Immunotherapy is an emerging powerhouse in cancer treatment. Early gains being made in multiple tumor types provide a glimpse of the effectiveness of several agents and regimens. While longer follow-up is needed, the results have analysts talking about a big shift in the war on cancer. Joe Dysart reports

Leadership Exchange: Thinking More Like a Patient

Leadership Exchange: Thinking More Like a Patient

A major information explosion is just the tip of the iceberg in the paradigm shift that is taking place between pharma, marketers and the patients that they serve. James Chase asks experts from across the patient-to-pharma spectrum how the industry can negotiate the new environment to successfully put patients first

Biotech Report: Ultra Man

Biotech Report: Ultra Man

Innovation is still valued in the orphan-drug space, but the reimbursement bar is rising. NPS Pharma’s Eric Pauwels, who’s launched five ultra-rare disease products, explains how these biotech brands can demonstrate their value. Marc Iskowitz reports